3-octadecanamido-2-ethoxypropylphosphocholine has been researched along with Leukemia, Myeloid, Acute in 1 studies
*Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, LW; Marx, MH; Modest, EJ; Noseda, A; Piantadosi, C | 1 |
1 other study(ies) available for 3-octadecanamido-2-ethoxypropylphosphocholine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine.
Topics: Amides; Cell Division; Humans; Leukemia, Myeloid, Acute; Magnetic Resonance Spectroscopy; Phosphatidylcholines; Protein Kinase C; Structure-Activity Relationship; Tumor Cells, Cultured | 1988 |